77 related articles for article (PubMed ID: 26084616)
1. Clinical significance of serum caveolin-1 levels in melanoma patients.
Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D
Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients.
Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
Melanoma Res; 2014 Oct; 24(5):475-9. PubMed ID: 24999757
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum claudin-1 levels in melanoma patients.
Tas F; Bilgin E; Erturk K; Duranyildiz D
Melanoma Res; 2016 Aug; 26(4):377-81. PubMed ID: 26886788
[TBL] [Abstract][Full Text] [Related]
4. Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma.
Tas F; Karabulut S; Yasasever CT; Duranyildiz D
Tumour Biol; 2014 Jul; 35(7):7233-7. PubMed ID: 24771267
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum caveolin-1 levels in gastric cancer patients.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Exp Oncol; 2018 Dec; 40(4):323-327. PubMed ID: 30593761
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum M30 and M65 levels in melanoma.
Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
[TBL] [Abstract][Full Text] [Related]
8. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
Tas F; Bilgin E; Karabulut S; Duranyildiz D
Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
[TBL] [Abstract][Full Text] [Related]
10. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
11. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of coagulation assays in melanoma.
Tas F; Ciftci R; Kilic L; Bilgin E; Keskin S; Sen F; Yildiz I; Yasasever V
Melanoma Res; 2012 Oct; 22(5):368-75. PubMed ID: 22889867
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma.
Tas F; Bilgin E; Erturk K; Duranyildiz D
Asian Pac J Cancer Prev; 2017 Mar; 18(3):599-601. PubMed ID: 28440609
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma.
Tas F; Bilgin E; Karabulut S; Erturk K; Duranyildiz D
BBA Clin; 2016 Jun; 5():166-9. PubMed ID: 27141440
[TBL] [Abstract][Full Text] [Related]
16. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of serum VEGF in melanoma patients: a pilot study.
Ascierto PA; Leonardi E; Ottaiano A; Napolitano M; Scala S; Castello G
Anticancer Res; 2004; 24(6):4255-8. PubMed ID: 15736481
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444
[TBL] [Abstract][Full Text] [Related]
20. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome.
Tas F; Bilgin E; Karabulut S; Tastekin D; Duranyildiz D
Mol Clin Oncol; 2016 Apr; 4(4):655-659. PubMed ID: 27073685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]